Emulate Bio Uk Ltd

Emulate Bio Uk Ltd is a small, active company based in Bristol, UK, founded five years ago in 2020. With £966,738 in assets and a virtual address shared by seventy-one other companies, it’s a relatively lean operation with six employees and one director. The company regularly imports machinery, boilers, and mechanical appliances; parts, with 15 months of import activity recorded, the latest in February 2025. It's a private limited company, and no owners are officially listed, likely because each shareholder holds less than twenty-five percent of the shares.

The company's website, emulateorganchips.com, showcases a platform for research and experimental development within biotechnology. It’s not an e-commerce site, but rather a provider of organ-on-a-chip technology and related services. The site details a range of products, including organ models like BrainChips and KidneyChips, alongside consumables, bio-kits, and software. The focus is on providing researchers with tools to model human diseases and reduce reliance on animal testing. Events and blog posts highlight the company’s involvement in industry discussions and its commitment to innovation.

Financially, Emulate Bio Uk Ltd shows a mixed picture. Cash bank on hand has plummeted 90% to just £37,000, while debtors have ballooned by 290% to £930,000—a significant increase that could indicate delayed payments or a shift in credit terms. Creditors have also risen 70% to £110,000. The company’s net assets have grown substantially, increasing by 310% to £740,000, and comprehensive income has decreased slightly by 7.7% to £48,000. The company meets two of three conditions to be considered small, with turnover under £10.2m, assets under £5.1m, and fewer than 50 employees. The lack of a named auditor suggests exemption as a small company, and the financial statements are audited.

Overall, Emulate Bio Uk Ltd appears to be navigating a period of growth and change. The surge in debtors could be a cause for concern, but the substantial increase in net assets suggests the company is attracting investment or generating strong revenue. The company’s focus on cutting-edge biotechnology and its commitment to human-relevant research positions it well for future success, although the reliance on its parent company Emulate, Inc. for support remains a key factor.

Registered in England/Wales under the registration number 12561698, with a registered address at BS1 6FL, United Kingdom, 10 Temple Back, Bristol, Suite 2 First Floor.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.